FDA Grants PRTC's LYT-200 Fast Track Designation | Company Announcement
Investegate announcements from FDA Grants PRTC's LYT-200 Fast Track Designation
Source: investegate.co.uk
Founded Entity Gallop News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Founded Entity Gallop. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Founded Entity Gallop Today - Breaking & Trending Today
PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia
LYT-200 is being advanced in hematological malignancies such as acute myeloid leukemia and high-risk myelodysplastic syndrome , and locally advanced/metastatic solid tumors, including head and neck...
Source: marketscreener.com